Levolin 1 Tablet contains Levosalbutamol 1 mg, a selective β2-adrenergic receptor agonist primarily used as a bronchodilator in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). By stimulating β2-adrenergic receptors in the bronchial smooth muscle, Levosalbutamol induces relaxation of airway muscles, leading to bronchodilation and improved airflow. This action helps alleviate symptoms including wheezing, shortness of breath, and bronchospasm. Levolin 1 Tablet is indicated for the relief and prevention of bronchospasm associated with reversible obstructive airway diseases. It is also utilized as a maintenance therapy to reduce the frequency and severity of asthma attacks. The rapid onset of action makes it suitable for acute symptom relief, while its selectivity for β2 receptors minimizes cardiac side effects commonly seen with non-selective β-agonists. Dosage and administration should be individualized based on the patient’s clinical response and severity of symptoms, with careful monitoring for potential adverse effects such as tremors, palpitations, headache, and muscle cramps. Caution is advised in patients with cardiovascular disorders, hyperthyroidism, or diabetes mellitus. Levolin 1 Tablet should be used under medical supervision to ensure optimal therapeutic outcomes and minimize risks.